KYVERNA TAMING AUTOIMMUNITY Trademark

Trademark Overview

On Friday, September 4, 2020, a trademark application was filed for KYVERNA TAMING AUTOIMMUNITY with the United States Patent and Trademark Office. The USPTO has given the KYVERNA TAMING AUTOIMMUNITY trademark a serial number of 90160254. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, May 27, 2024. This trademark is owned by Kyverna Therapeutics, Inc.. The KYVERNA TAMING AUTOIMMUNITY trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
kyverna taming autoimmunity

General Information

Serial Number90160254
Word MarkKYVERNA TAMING AUTOIMMUNITY
Filing DateFriday, September 4, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, May 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, February 23, 2021

Trademark Statements

Description of MarkThe mark consists of a design element resembling a crosshair surrounded by lines resembling sun rays on the left of the words "KYVERNA" stylized and "TAMING AUTOIMMUNITY" in stacked formation.
Goods and ServicesTherapeutic pharmaceutical for the treatment of autoimmune disease; therapeutic pharmaceuticals and cell therapy products in the nature of cells for medical or clinical use for the treatment of autoimmune disease; cell therapy products, namely, genetically engineered immune cells for medical or clinical use for the treatment of autoimmune disease
Indication of Colors claimedColor is not claimed as a feature of the mark.
Translation of Words in MarkThe English translation of the word "KYVERNA" in the mark is "GOVERN" or "RULE".
NOT AVAILABLE"TAMING AUTOIMMUNITY"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 9, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameKyverna Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608
Party NameKyverna Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBerkeley, CA 94710

Trademark Events

Event DateEvent Description
Tuesday, September 8, 2020NEW APPLICATION ENTERED
Friday, October 9, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, October 10, 2020NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 12, 2021ASSIGNED TO EXAMINER
Friday, January 15, 2021EXAMINER'S AMENDMENT ENTERED
Friday, January 15, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, January 15, 2021EXAMINERS AMENDMENT -WRITTEN
Friday, January 15, 2021EXAMINERS AMENDMENT E-MAILED
Friday, January 15, 2021NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, February 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 23, 2021PUBLISHED FOR OPPOSITION
Tuesday, February 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Friday, March 26, 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, March 26, 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 26, 2021APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, September 29, 2021ASSIGNED TO EXAMINER
Tuesday, April 20, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 16, 2021SOU TEAS EXTENSION RECEIVED
Monday, August 16, 2021SOU EXTENSION 1 FILED
Monday, August 16, 2021SOU EXTENSION 1 GRANTED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 4, 2022SOU EXTENSION 2 GRANTED
Friday, February 4, 2022SOU TEAS EXTENSION RECEIVED
Friday, February 4, 2022SOU EXTENSION 2 FILED
Monday, March 20, 2023SOU TEAS EXTENSION RECEIVED
Friday, September 22, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 19, 2022SOU TEAS EXTENSION RECEIVED
Friday, August 19, 2022SOU EXTENSION 3 FILED
Friday, August 19, 2022SOU EXTENSION 3 GRANTED
Tuesday, August 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 20, 2023SOU EXTENSION 4 FILED
Monday, March 20, 2023SOU EXTENSION 4 GRANTED
Wednesday, March 22, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023SOU EXTENSION 5 FILED
Tuesday, October 3, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, October 3, 2023SOU EXTENSION 5 GRANTED
Wednesday, October 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 27, 2024ABANDONMENT - NO USE STATEMENT FILED

Related Keywords

autoimmunity taming kyverna disease treatment autoimmune cells medical clinical therapeutic products therapy cell